For the year ending 2025-12-31, PTGX has $668,188K in assets. $53,481K in debts. $128,390K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 128,390 | |||
| Marketable securities | 438,974 | |||
| Receivable from collaboration partner | 121 | |||
| Prepaid expenses and other current assets | 10,089 | |||
| Total current assets | 577,574 | |||
| Marketable securities - noncurrent | 78,638 | |||
| Property and equipment, net | 3,860 | |||
| Restricted cash - noncurrent | 287 | |||
| Operating lease right-of-use asset | 7,829 | |||
| Total assets | 668,188 | |||
| Accounts payable | 5,339 | |||
| Accrued expenses and other payables | 28,269 | |||
| Deferred revenue | 9,550 | |||
| Operating lease liability | 2,283 | |||
| Total current liabilities | 45,441 | |||
| Operating lease liability - noncurrent | 8,040 | |||
| Total liabilities | 53,481 | |||
| Common stock, 0.00001 par value, 180,000,000 shares authorized 62,577,897 and 61,035,139 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 1 | |||
| Additional paid-in capital | 1,084,736 | |||
| Accumulated other comprehensive income (loss) | 641 | |||
| Accumulated deficit | -470,671 | |||
| Total stockholders' equity | 614,707 | |||
| Total liabilities and stockholders' equity | 668,188 | |||
Protagonist Therapeutics, Inc (PTGX)
Protagonist Therapeutics, Inc (PTGX)